JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.
Survey on Clinical Practices for Treating Pediatric Eosinophilic Esophagitis
Assessing Current Clinical Practices
Sign in to Google
to save your progress.
Learn more
* Indicates required question
Email
*
Your email
Name, Surname :
Your answer
University, Hospital, other :
*
Your answer
What is your country of practice?
*
Your answer
What is your medical specialty?
*
Pediatrics - Ped GI
Allergy and Immunology
Gastroenterology
Pediatric Surgery
Other:
How long have you been working in the area of EoE?
<1 year
1-5 years
5-10 years
> 10 years
Clear selection
How many individuals with EoE are currently under the care of your medical unit?
<50
50-100
100-150
150-200
>200
Clear selection
Please specify which patient population you manage: adults, children, or both?
*
Children (<=18 years)
Adults
Both
Other:
Do you apply a shared decision-making strategy in EoE management before deciding any treatment?
*
Yes
No
It depends on the case
Other:
What is your most used
FIRST-line therapy
option for inducing remission in patients with EoE?
*
Elimination diet
PPIs
Topical steroids
Combination therapy (2 or 3 options at the same time)
If the first-line therapy option for inducing remission in patients with EoE is unsuccessful, what is your most used
SECOND-line therapy option?
*
change medication (e.g. from PPI to topical steroid etc.)
combine medications (Add steroids to PPI etc)
combine medication and elimination diet
Add Dupilumab
Other:
If second-line therapy for inducing remission in patients with EoE is
unsuccessful
, what treatment option do you typically pursue?
*
Increase the dosage of medications
Combine medications
Combine medications and diet
Elemental diet
Other:
If you use
MULTIPLE therapeutic strategies
(such as a combination of medications and diet) for induction therapy, how long do you keep them before weaning?
*
3 months (just after the induction)
6 months
1 year
Until the patient has side effects
Other:
If a patient achieves remission after induction treatment with medications (PPIs, TCS),
what is your approach to maintaining remission
?"
*
maintain the same medication dose
reduce 50% from the initial medication dose
reduce less than 50% from the initial medication dose
Other:
Do you perform an endoscopy after first-line medications for induction (PPIs and TCS) and when?
*
Yes, 3 months
Yes, 6 months
Yes, 1 year
No, only in case of symptoms
Other:
Do you routinely perform an
endoscopy before reducing the dose
, or do you sometimes reduce the dose without repeating the endoscopy?
*
Yes, I always perform an endoscopy before reducing the dose
No, I do not always perform an endoscopy before reducing the dose
I never reduce the dose
Other:
After reducing the dose of medication for maintenance therapy,
how soon do you typically perform an endoscopy to monitor disease activity?
Within 3 months
Within 6 months
Within 1 year
> 1 year
Only when symptoms reoccur
I perform endoscopy at the discretion of the patient or caregiver
Other:
Clear selection
When using a nutritional approach as therapy for EoE, what is
your preferred dietary scheme or protocol
?"
*
step up ( from 2, to 4, to 6 foods)
top down (from 6 to 1)
top down with a two food order ( e.g. 6 -->4-->2-->0)
1 food elimination diet (cow's milk free diet)
Other:
Is there a registered dietitian or nutritionist on staff in your unit or clinic to provide guidance on nutritional approaches for EoE?
Yes
No
Clear selection
If a registered dietitian or nutritionist is available in your unit or clinic to provide guidance on nutritional approaches for EoE, are they specialized in providing care to pediatric patients?
Yes
No
Other:
Clear selection
When using proton pump inhibitors (PPIs) as therapy to induce remission for EoE, what is your preferred dose?
< 1mg/kg/day
1mg/kg/day
2mg/kg/day
>2mg/kg/day
Other:
Clear selection
Do you prefer to prescribe the daily dose of PPI as a single dose or divided into two doses per day?
once/day
twice/day
Other:
Clear selection
When using
Oral Viscous Budesonide
as therapy to induce remission for EoE, what is your preferred dose of topical steroids IN CHILDREN ?
0.5mg-1mg/day (0.5mg fro <150cm, 1mg > 150cm into two doses)
1mg-2mg/day (1mg fro <150cm, 2mg > 150cm, into two doses)
2-4mg/day (2 mg fro <150cm, 4mg > 150cm, into two doses)
Clear selection
When using
Oral Viscous Budesonide
as therapy to induce remission for EoE, what is your preferred dose of topical steroids IN ADULTS ?
*
1mg/day
2mg/day
4mg/day
Other:
When using
Fluticasone
as therapy to induce remission for EoE, what is your preferred dose of topical steroids IN CHILDREN ?
*
440 mcg daily
880 mcg daily
1320 mcg daily
1760 mcg daily
other
Other:
When using
Fluticasone
as therapy to induce remission for EoE, what is your preferred dose of topical steroids IN ADULTS?
*
440 mcg daily
880 mcg daily
1320 mcg daily
1760 mcg daily
Other:
What is the your recommended dose for proton pump inhibitors (PPIs) when used as maintenance therapy for EoE?
<1mg/kg/day
1mg/kg/day
2mg/kg/day
>2mg/kg/day
Clear selection
What is the your recommended dose for
Oral Viscous Budesonide
when used as maintenance therapy for EoE?
<1mg/day
0.5-1mg/day (depending on age and height)
1-2mg/day (depending on age and height)
>2mg/day
Clear selection
What is the your recommended dose for
Fluticasone
when used as maintenance therapy for EoE?
*
440 mcg daily
880 mcg daily
1320 mcg daily
1760 mcg daily
Other:
Do you use Budesonide Orodispersible Tablets (Jorveza) in children?
*
Yes
No
I'm unable to do that, but I would like to
Other:
What dose of Jorveza do you recommend for induction therapy in patients with EoE?
0.5mg/dose, twice per day
1mg/dose, twice per day
1mg/dose, once per day
Other:
Clear selection
If a patient achieves complete remission with Jorveza, do you typically reduce the medication dose?"
Yes
No
Depending on the initial severity
Other:
Clear selection
If yes, which dose do you use as maintenance therapy?
0.5mg/dose, twice per day
1mg/dose, once per day
0.5mg/dose, once per day
<0.5mg/day
Clear selection
After achieving remission in a patient with a reduced dose, at what interval do you perform follow-up endoscopy to monitor disease activity?
in 6 months
in 12 months
in 18 months
only in case of symptoms
Clear selection
Under what circumstances would you initiate treatment with Dupilumab for patients with EoE?
*
When available therapies fail to induce remission
When patients are unable to tolerate or have contraindications to other therapies
When patients have comorbidities or other indications for Dupilumab
As a first-line therapy in select cases
I do not typically use Dupilumab in my practice
Other:
In what situations would you choose dupilumab as the initial treatment option for EoE?
*
When the patient has severe EoE with high levels of esophageal inflammation and fibrosis
Patients who prefer a biologic therapy over other treatment options
As a first-line therapy for all patients with EoE
When patients have comorbidities or other indications for Dupilumab
Other:
Submit
Clear form
Never submit passwords through Google Forms.
This content is neither created nor endorsed by Google. -
Terms of Service
-
Privacy Policy
Does this form look suspicious?
Report
Forms
Help and feedback
Help Forms improve
Report
